Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schwab

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Preclinical evaluation of the breast cancer cell-binding peptide, p160Vasileios Askoxylakis, Sabine Zitzmann, Walter Mier, et al.
Cancer Research|April 19, 2006
Suppression of centrosome amplification after DNA damage depends on p27 accumulationEiji Sugihara, Masayuki Kanai, Soichiro Saito, et al.
Cancer Research|March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cellsKai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastomaJessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Cancer Cell|November 27, 2002
Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastomaBernd Berwanger, Oliver Hartmann, Eckhard Bergmann, et al.
Neoplasia (New York, N.Y.)|August 8, 2008
Generation and characterization of novel local and metastatic human neuroblastoma variantsIdo Nevo, Orit Sagi-Assif, Liat Edry Botzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratificationAndré Oberthuer, Frank Berthold, Patrick Warnat, et al.
Human Molecular Genetics|January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosisDaniel Dreidax, Sina Gogolin, Christina Schroeder, et al.
Cancer Research|April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastomaDaniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Preclinical evaluation of the breast cancer cell-binding peptide, p160Vasileios Askoxylakis, Sabine Zitzmann, Walter Mier, et al.
Cancer Research|April 19, 2006
Suppression of centrosome amplification after DNA damage depends on p27 accumulationEiji Sugihara, Masayuki Kanai, Soichiro Saito, et al.
Cancer Research|March 10, 2011
CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cellsKai-Oliver Henrich, Tobias Bauer, Johannes Schulte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patientsKai-Oliver Henrich, Matthias Fischer, Daniel Mertens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
Heterogeneity of the MYCN oncogene in neuroblastomaJessica Theissen, Marc Boensch, Ruediger Spitz, et al.
Cancer Cell|November 27, 2002
Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastomaBernd Berwanger, Oliver Hartmann, Eckhard Bergmann, et al.
Neoplasia (New York, N.Y.)|August 8, 2008
Generation and characterization of novel local and metastatic human neuroblastoma variantsIdo Nevo, Orit Sagi-Assif, Liat Edry Botzer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2006
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratificationAndré Oberthuer, Frank Berthold, Patrick Warnat, et al.
Human Molecular Genetics|January 25, 2013
Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosisDaniel Dreidax, Sina Gogolin, Christina Schroeder, et al.
Cancer Research|April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastomaDaniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.
Pageof 7